A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

✍ Scribed by Penson, Richard T.; Moore, Kathleen M.; Fleming, Gini F.; Braly, Patricia; Schimp, Veronica; Nguyen, Hoa; Matulonis, Ursula A.; Banerjee, Susana; Haluska, Paul; Gore, Martin; Bodurka, Diane C.; Hozak, Rebecca R.; Joshi, Adarsh; Xu, Yihuan; Schwartz, Jonathan D.; McGuire, William P.

• Book ID: 127012746
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 637 KB
• Volume: 134
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.06.029